Wilmington, DE, United States of America

Dengjin Wang

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Dengjin Wang

Introduction

Dengjin Wang is a notable inventor based in Wilmington, DE (US), recognized for his significant contributions to the field of pharmaceuticals. He holds a total of six patents, showcasing his innovative approach to drug development and treatment methodologies.

Latest Patents

Among his latest patents is a process for making a PD-1/PD-L1 inhibitor and its salts and crystalline forms. This application focuses on the preparation of a specific PD-1/PD-L1 inhibitor, which is useful in treating various diseases, including infectious diseases and cancer. The detailed process involves intermediates that enhance the efficacy of the inhibitor, demonstrating Wang's commitment to advancing medical science.

Career Highlights

Dengjin Wang has worked with prominent companies such as Incyte Corporation and Incyte Holdings Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of therapeutic solutions.

Collaborations

Wang has collaborated with notable colleagues, including Jiacheng Zhou and Pingli Liu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Dengjin Wang's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…